Mortality during adjuvant treatment of early breast cancer with cyclophosphamide, methotrexate, and fluorouracil

被引：31

作者：

Colleoni, M

Price, KN

Castiglione-Gertsch, M

Gelber, RD

Coates, AS

Goldhirsch, A

机构：

[1] European Inst Oncol, Div Med Oncol, I-20141 Milan, Italy

[2] IBCSG Stat Ctr, Boston, MA USA

[3] Frontier Sci & Technol Res Fdn, Boston, MA USA

[4] IBCSG Coordinating Ctr, Bern, Switzerland

[5] Australian New Zealand Breast Canc Trials Grp, Sydney, NSW, Australia

[6] Australian Canc Soc, Sydney, NSW, Australia

[7] Osped Civico, Lugano, Switzerland

来源：

LANCET | 1999年 / 354卷 / 9173期

关键词：

D O I：

10.1016/S0140-6736(99)02015-2

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Combined chemotherapy for early breast cancer with cyclophosphamide, methotrexate, and fluorouracil has low associated mortality, but related deaths were seen among women aged 65 years or older in International Breast Cancer Study Group trials.

引用

页码：130 / 131

页数：2